Cloud vs On-Premise AI for Pharmaceutical R&D

Summary: Pharmaceutical organizations face deployment decisions when adopting AI drug discovery platforms. Cloud-hosted services offer speed and scalability. On-premise deployment provides maximum data control. Understanding the trade-offs helps organizations align infrastructure with research requirements.

Why Deployment Architecture Matters

Drug discovery generates valuable proprietary data: target hypotheses, molecular designs, binding predictions, structure-activity relationships. How this data is stored, processed, and protected has implications for intellectual property, regulatory compliance, and competitive advantage.

The deployment model of AI drug discovery platforms—where the software runs and where data resides—directly affects data governance capabilities and operational control.

Deployment Options

Cloud-Hosted (Vendor-Managed)

The platform runs in the vendor's cloud infrastructure. Users access it through web interfaces or APIs.

Private Cloud (Customer Account)

The platform runs within the customer's own cloud account (AWS, Azure, GCP).

On-Premise Deployment

The platform runs on hardware within the organization's own data center or facilities.

Comparison Matrix

Factor Vendor Cloud Private Cloud On-Premise
Time to deploy Days Weeks Weeks-Months
Data residency control Limited Full (within cloud) Full (physical)
Infrastructure management Vendor Customer Customer
Scalability High High Limited by hardware
Upfront cost Low Medium High
Air-gap capability No No Yes

There is no universally "best" deployment model. The right choice depends on data sensitivity, regulatory requirements, existing infrastructure, and organizational capabilities.

Key Decision Factors

Data Sensitivity

How sensitive is the research data being processed? Early-stage exploratory work may have different requirements than late-stage programs approaching clinical trials or regulatory filings.

Regulatory Requirements

Some regulatory frameworks impose specific requirements on data handling, residency, or processing location. Organizations in regulated environments should verify deployment models satisfy compliance obligations.

IT Capabilities

Private cloud and on-premise deployments require internal technical capabilities to manage infrastructure. Organizations without dedicated IT resources may prefer vendor-managed options.

Model Training Considerations

Some AI platforms improve their models using customer data. Organizations should understand whether their data contributes to model training and whether this can be excluded contractually.

Total Cost of Ownership

Vendor-hosted services have lower upfront costs but ongoing subscription fees. On-premise deployment has higher upfront investment but may have lower long-term costs for intensive usage. Private cloud sits between these extremes.

Hybrid Approaches

Some organizations adopt hybrid strategies:

Questions to Ask Vendors

Enterprise Deployment Options

Learn about CycloGen's private and on-premise deployment options for pharmaceutical R&D.

View Services